Poway, California
United States
21
2021-01-28
The entities that hold a legal rights for patent applications filed by inventor Crawford Brett E.:
Brett E. Crawford from Poway, US has applied for patents for these inventions. The list has both pending applications and granted patents:
METHODS OF DIAGNOSING A DISEASE AND METHODS OF MONITORING TREATMENT OF A DISEASE BY QUANTIFYING A NON-REDUCING END GLYCAN RESIDUAL COMPOUND AND COMPARING TO A SECOND BIOMARKER
#2 | 2021-01-21DETECTION OF OLIGOSACCHARIDES
#3 | 2019-08-15Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
#4 | 2018-09-13Methods of diagnosing mucopolysaccharidosis (MPS) I and methods of monitoring treatment of MPS by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker
#5 | 2018-03-22Detection of oligosaccharides
#6 | 2017-11-09Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
#7 | 2016-11-10Methods of determining the presence, identity, and/or severity of mucopolysaccharidosis (MPS) VI and IVA
#8 | 2016-06-02Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
#9 | 2015-10-29Detection of oligosaccharides
#10 | 2014-12-04Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker
#11 | 2014-10-16Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
#12 | 2013-08-22Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker
#13 | 2013-06-13Methods of determining the presence and/or amount of a biomarker to determine the presence, identity, and/or severity of a lysosomal storage or neurological disorder
#14 | 2012-11-22GLYCOSAMINOGLYCAN INHIBITORS
#15 | 2012-04-26N-LINKED GLYCAN BIOSYNTHESIS MODULATORS
#16 | 2012-01-12Detection of oligosaccharides
#17 | 2011-12-22Polymer end group detection
#18 | 2010-09-30GANGLIOSIDE BIOSYNTHESIS MODULATORS
#19 | 2010-07-22Detection of oligosaccharides
#20 | 2010-07-08Quantification of non-reducing end glycan residual compounds
#21 | 2010-02-25HEPARAN SULFATE INHIBITORS
286600 ⎘